Background: Paclitaxel (BMS-181339: Taxol) is a promising agent against previously treated breast cancer. The antitumor activity of paclitaxel was evaluated using five human breast carcinoma xenografts in nude mice. Methods: Paclitaxel at 20 mg/kg dissolved in 0.2 ml ethanol/cremophor EL solution wa
โฆ LIBER โฆ
Combined cytotoxic and endocrine therapy for human breast carcinoma (Br-10) serially transplanted into nude mice
โ Scribed by Tetsuro Kubota; Koichi Kubouchi; Jun-ichi Koh; Fumiki Asanuma; Koji Enomoto; Kyuya Ishibiki; Osahiko Abe
- Book ID
- 112755354
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 434 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1436-2813
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Antitumor activity of paclitaxel against
โ
Kubota, Tetsuro; Matsuzaki, Shinjiro Wilson; Hoshiya, Yasunori; Watanabe, Masahi
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 98 KB
Human breast carcinoma (ZR-75-1) seriall
โ
Tetsuro Kubota; Shoichi Oka; Toshiaki Utsumi; So Inoue; Masahiko Kuzuoka; Akihik
๐
Article
๐
1989
๐
Springer
๐
English
โ 390 KB
Antitumor Activity and Pharmacokinetics
โ
Kubota, Tetsuro ;Suto, Akihiko ;Josui, Kazuya ;Ishibiki, Kyuya ;Abe, Osahiko ;Ya
๐
Article
๐
1990
๐
Wiley (Blackwell Publishing)
๐
English
โ 390 KB
Potentiation of antitumor activity of mi
โ
Oka, Shoichi; Kubota, Tetsuro; Takeuchi, Tooru; Kitajima, Masaki
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 579 KB
The effect of experimental cancer chemotherapy with mitomycin C (MMC) was studied using three estrogen-receptor (ER)-positive (MCF-7, R-27, and Br-10) and one ER-negative (MX-1) human breast carcinoma xenograft serially transplanted into nude mice, and the effect of estradiol (E2) priming on the ant
Combined effect of angiogenesis inhibito
โ
K. Noguchi; K. Sakurai; N. Nishimura; H. Kishimoto; Y. Takahashi; T. Yanagisawa;
๐
Article
๐
1999
๐
Elsevier Science
๐
English
โ 122 KB